Delivery Order SPE2DR25D1100-SPE2DR26FCM0D
- Not listed
- The Defense Logistics Agency awarded a $1,842.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Loteprednol Etabonate 0.2% ophthalmic drops in 5 mL quantities. The contract, which represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), is non-competitive and scheduled for completion by August 1, 2025. Performance will be fulfilled...
- The Defense Logistics Agency awarded a delivery order valued at $3,096.94 to AmerisourceBergen Drug Corp for Loteprednol Etabonate 0.5% ophthalmic drops (5 mL) on August 18, 2025, with completion scheduled for August 19, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,886.24 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Loteprednol Etabonate 0.2% ophthalmic drops in 5ML quantities. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by July 22, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. This delivery order is issued under...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $1,240.45 firm fixed-price contract is for the delivery of Loteprednol Etabonate 0.5% ophthalmic drops. The order has a completion date of June 23, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Loteprednol Etabonate 0.2% ophthalmic drops in a 5 mL unit, with a ceiling value of $1,267.04. This competitive award utilizes a firm fixed price structure and is classified as a child contract under a larger vehicle. The performance location is identified as Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. No set-aside designation was applied...
- This delivery order, valued at $2,630.16, was awarded on August 19, 2025, to AmerisourceBergen Drug Corp for the supply of Loteprednol Etabonate 0.5% ophthalmic suspension. The contract is a firm fixed-price delivery order issued under the Defense Logistics Agency's Medical Supply Chain program, with performance to be completed by August 19, 2025, at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was made on a competitive, non-set-aside basis, consistent with the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Loteprednol Etabonate 0.5% ophthalmic drops in 5 mL quantities, with a ceiling value of $2,508.45. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract calls for completion by May 7, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $940 to Amerisourcebergen Drug Corporation for LOTEPREDNOL eye drops. The single award was issued under an unspecified governmentwide acquisition contract vehicle or indefinite delivery/indefinite quantity contract held by Amerisourcebergen. Performance will occur at the prime contractor's facility in Conshohocken, Pennsylvania by August 22, 2023. No subcontractors or set aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,273.07 firm fixed-price delivery order is for the supply of loteprednol etabonate 0.5% eye drops, a medication used for the treatment of various eye conditions. The contract has an ultimate completion date of May 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- Defense Logistics Agency awarded Amerisourcebergen Drug Corp a $3,039.40 firm fixed price delivery order for Loteprednol Etabonate 0.5% eye drops. As the prime contractor, Amerisourcebergen will provide 15mL of the specified medication to the agency by the scheduled completion date of October 20, 2023. The place of performance is Conshohocken, Pennsylvania. No set-aside designation was used for this order placed under an existing vehicle by the Defense Logistics Agency to support its medical...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCM0DDelivery Order
The Defense Logistics Agency awarded a $1,092.99 delivery order to AmerisourceBergen Drug Corp for Loteprednol Etabonate 0.2% ophthalmic drops (5 mL) on October 31, 2025, with completion targeted for November 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, fulfills this order under its existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.999 billion prime vehicle that extends through December 2026 and serves as the primary pharmaceutical support mechanism for military healthcare programs worldwide. As a child delivery order, this award represents a routine pharmaceutical procurement supporting military medical operations. AmerisourceBergen's extensive portfolio of federal contracts demonstrates its established capability in delivering specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The loteprednol etabonate formulation being procured is a topical corticosteroid commonly used in military and veteran ophthalmic care for inflammatory eye conditions, reflecting the company's role in sustaining critical pharmaceutical supply chains for federal health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 10/31/25 |